| AXGN Market Cap History Table | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Below is a table of the AXGN market cap history going back to 3/26/2010:
Also see: AXGN Shares Outstanding History and AXGN YTD Return |
AXGN Market Cap History — AxoGen Capitalization Over Time
As of 4/24/2026 AxoGen has a market cap of 2.09 billion. Investors often follow the AXGN market cap history to compare the size of the company over time.
This page shows AXGN market capitalization trends over time, with 68 market cap datapoints presented, dating back to 3/26/2010.
| AXGN Market Cap History Chart | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
AXGN Historical Market Cap: +36.51% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| AXGN Stock Price Chart |
| About Axogen Inc |
| Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its products include Avance nerve graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, Axotouch Two-Point Discriminator and Axoguard HA+ Nerve Protector. Avance nerve graft is a biologically active processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site. We show 68 historical shares outstanding datapoints in our AXGN shares outstanding history coverage, used to compute AXGN market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing AXGN market cap history over the course of time is important for investors interested in comparing AXGN's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of AXGN versus a peer is one thing; comparing AXGN market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like AXGN can fluctuate over the course of history. With this page we aim to empower investors researching AXGN by allowing them to research the AXGN market cap history. |
| AXGN Current Stock Quote |
Quotes delayed 20 minutes  Free AXGN Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| AXGN Share Performance |
| Market Cap Peers |
| AxoGen (AXGN) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
AXGT Market Cap History AXLA Market Cap History AXNX Market Cap History AXSM Market Cap History AYLA Market Cap History AYTU Market Cap History AZN Market Cap History AZRX Market Cap History AZYO Market Cap History BACK Market Cap History More Healthcare companies » |
AXGN Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
